Characterization and clinical outcomes of low hormonal receptor positive / HER2 negative early breast cancer

被引：0
|
作者：
Karnmanee, J. [1 ]
Dajsakdipon, T. [2 ]
Sripaiboonkij, N. [3 ]
Dejthevaporn, T. [2 ]
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok, Thailand
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Comprehens Canc Ctr, Bangkok, Thailand
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
299P
引用
收藏
页码：S340 / S340
页数：1
相关论文
共 50 条
  • [11] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Chen, Mengdi
    Chen, Weilin
    Liu, Deyue
    Chen, Weiguo
    Shen, Kunwei
    Wu, Jiayi
    Zhu, Li
    BREAST CANCER, 2022, 29 (05) : 844 - 853
  • [12] The clinical importance of the new category, ER low-positive in the ER expression HER2 negative early breast cancer
    Wakako, Tajiri
    CANCER RESEARCH, 2022, 82 (04)
  • [13] EARLY RELAPSE OF HER2 POSITIVE BREAST CANCER
    Zelen, Teodora Brdar
    Prica, Anja
    Jovisevic, Marija
    BREAST, 2023, 71 : S58 - S58
  • [14] Characterization of HER2 positive breast cancer in Tunisia
    Yaiche, R.
    Houcine, Y.
    Saidi, E.
    Saadallah, F.
    Kamoun, S.
    Meddeb, K.
    Driss, M.
    VIRCHOWS ARCHIV, 2024, 485 : S210 - S210
  • [15] Comparison of EndoPredict and MammaPrint in hormone receptor positive, HER2 negative breast cancer
    Boesl, A.
    Spitzmueller, A.
    Haid, A.
    Jasarevic, Z.
    Baruschke, K.
    Jaeger, S.
    Offner, F.
    BREAST, 2015, 24 : S46 - S47
  • [16] Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours
    Tovey, S. M.
    Edwards, J.
    Brown, S. B.
    Mallon, E.
    Cooke, T. G.
    EJC SUPPLEMENTS, 2008, 6 (09): : 105 - 106
  • [17] Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer
    Harbeck, N.
    BREAST, 2017, 32 : S18 - S18
  • [18] Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience
    Okines, Alicia
    Irfan, Tazia
    Asare, Bernice
    Mohammed, Kabir
    Osin, Peter
    Nerurkar, Ashutosh
    Smith, Ian E.
    Parton, Marina
    Ring, Alistair
    Johnston, Stephen
    Turner, Nicholas C.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (03) : 563 - 571
  • [19] Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience
    Alicia Okines
    Tazia Irfan
    Bernice Asare
    Kabir Mohammed
    Peter Osin
    Ashutosh Nerurkar
    Ian E. Smith
    Marina Parton
    Alistair Ring
    Stephen Johnston
    Nicholas C. Turner
    Breast Cancer Research and Treatment, 2022, 192 : 563 - 571
  • [20] The Survival Benefit of Endocrine Therapy in Low Estrogen Receptor Positive/HER2 Negative Invasive Breast Cancer
    Alhamar, Mohamed
    Alkamachi, Bassam
    Mehrotra, Harshita
    Ohan, Hovsep
    Ali, Haythem
    Gupta, Nilesh
    Hassan, Oudai
    Chitale, Dhananjay
    Schultz, Daniel
    Allo, Ghassan
    Alkhoory, Wamidh
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 74 - 76
12345